Please use this identifier to cite or link to this item:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/33759Full metadata record
| ???org.dspace.app.webui.jsptag.ItemTag.dcfield??? | Value | Language |
|---|---|---|
| dc.contributor.advisor | 楊台鴻(Tai-Horng Young) | |
| dc.contributor.author | Hung-Hsing Lin | en |
| dc.contributor.author | 林弘欣 | zh_TW |
| dc.date.accessioned | 2021-06-13T05:45:40Z | - |
| dc.date.available | 2007-07-19 | |
| dc.date.copyright | 2006-07-19 | |
| dc.date.issued | 2006 | |
| dc.date.submitted | 2006-07-14 | |
| dc.identifier.citation | 1. Peppas NA. Hydrogels in Medicine and Pharmacy. Polymers CRC
Press. 1988 2. Sakurada I. Polyvinyl Alcohol Fibers. Barcel Dekker Inc. New York. 1985 3. Naito H. Non-anticoagulant hemodialysis using EVAL hollow fiber membrane dialyzer. Kuraray Co. Ltd. 1982 4. Grunkemeier JM, Tsai WB, Horbett TA. Hemocompatibility of treated polystyrene substrates: Contact activation, platelet adhesion, and procoagulant activity of adherent platelets. J Biomed Mater Res 1998; 41: 657-670. 5. Kulik E, Ikada Y, In vitro platelet adhesion to nonionic and ionic hydrogels with different water con- tents. J Biomed Mater Res 1996; 30: 295–304. 6. Okkema AZ, Cooper SL. Effect of carboxylate and/or sulphonate ion incorporation on the physical and blood-contacting properties of a polyetherurethane. Biomaterials 1991; 12 7: 668-76. 7. 台北捐血中心網站 http://www.tp.blood.org.tw/ 8. 何敏夫 編著,”血庫學”,p273-80,藝軒圖書出版社,2004 9. Hmel PJ, Kennedy A, Quiles JG, Gorogias M, Seelbaugh JP, Morrissette CR, Van Ness K, Reid TJ. Physical and thermal properties of blood storage bags: implications for shipping frozen components on dry ice. Transfusion 2002; 42; 836-846. 10. Zhu A, Zhang M, Zhang Z. Surface modification of ePTFE vascular grafts with O-carboxymethylchitosan. Polym Int 2004; 53: 15–19. 11. Kondoh A, Makino K, Matsuda T. Two-dimensional artificial extracellular matrix: bioadhesive peptide-immobilized surface 61 design. J Appl Polym Sci 1993; 47: 1983-1988. 12. Zingsem J, Glaser A, Zimmermann R, Weisbach V, Kalb R, Ruf A, Eckstein R. Paired Comparison of Apheresis Platelet Function After Storage in Two Containers. J CLIN APHERESIS 2001;16: 10-14 13. Hoffmeister KM, Felbinger TW, Herve´ Falet, Ce´ cile V. Denis, Bergmeier W, Mayadas TN, Von Andrian UH, Wagner DD, Stossel TP, Hartwig JH. The Clearance Mechanism of Chilled Blood Platelets. Cell 2003; 112: 87-97. 14. Michelson AD. Platelet Function Testing in Cardiovascular Diseases. Circulation 2004; 110: 489-93. 15. Wildt-Eggen JD, Schrijver JG, Bins M, Gulliksson H. Storage of platelets in additive solution : effects of magnesium and/or potassium. Transfusion 2002;42: 76-80. 16. Von Bruchhauausen F, Walter U editors. Platelets and Their Factors. Springer 1997; 382-385. 17. Homer KL, Wanstall JC. Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate. BRIT J PHARMACOL 2002; 13: 1071-1781. 18. Mowery KA, Schoenfisch MH, Saavedra JE, Keefer LK, Meyerhoff ME. Preparation and Charaterization of hydrophobic polymeric films that are thromboresistant via nitric oxide release. Biomaterials 2000; 21: 9-21. 19. Balakrishnana B, Kumarb DS, Yoshidab Y, Jayakrishnan A. Chemical modification of poly(vinyl chloride) resin using poly(ethylene glycol) to improve blood compatibility. Biomaterials 2005; 26: 3495-3502. 20. Van der Meer PF, Pietersz RNI, Reesink HW. Comparison of two platelet additive solutions. Transfusion Med 2001; 11: 193-197. 21. Beaulieu M, Lapointe Y, Vinet B. Stability of pO2, pCO2, and pH in Fresh Blood Samples Stored in a Plastic Syringe with Low Heparin in Relation to Various Blood-Gas and Hematological Parameters. 62 CLIN BIOCHEM 1999; 32 2: 101-107. 22. Zeiler T, Gritzka D, Karger R, Kretschmer V. The effect of ASA on platelet activation during apheresis and on in-vitro properties of stored platelet concentrates. TRANSFUSION 2004; 44: 1300-1305. 23. Ajili SH, Ebrahimi NG, Khorasani MT. Study in Thermoplastic Polyureyhane/Polypropylene(TPU/PP) Blend as a Blood Bag Material. J APPL POLYM SCI 2003; 89: 2496-2501. 24. Rainer H., Stefanie M., The Clinical Pharmacology Of L-arginine. Annu Rev Pharmacol Toxicol 2001; 41: 79-101. 25. Yance DR, L-arginine. 2005/11/16 26. Gundu H. R. Rao. Handbook of Platelet Physiology and Pharmacology. Kluwer Academic Publishers 1999; 175 | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/33759 | - |
| dc.description.abstract | 本研究是利用乾式法將高分子聚氯乙烯、聚乙烯醇與乙烯-乙烯
醇共聚合物製成薄膜後,用化學改質的方法將薄膜表面接枝胺基,分 別為聚氯乙烯以二胺類改質,聚乙烯醇與乙烯-乙烯醇共聚合物以二 異氰酸鹽將表面之氫氧基接枝改質成胺基,再分別利用Micro-ATR 與Orange II 來分析薄膜改質前後官能基的變化與其接枝量。 同時將左旋-精氨酸作為血小板儲存時的添加劑,來比較血小板 儲存時材料與添加劑對於血小板之影響,所利用的測試方法分別為細 胞活性的MTT 與LDH、血小板凝集能力的凝集測試、血小板活化、 存活與死亡的抗體標定與血小板貼附與型態改變的SEM 照片,利用 這些方法來檢定血小板在儲存時的各種狀況。 血小板在經由儲存測試後可以發現經化學改質後的高分子薄膜 可以在初期利用其較為親水的表面提供一個血小板較不易貼附的環 境,並且能維持血小板較好的活性與功能,只是此項差異性會隨著儲 存時間的延長而逐漸消失,而將左旋-精氨酸作為添加劑則可將材料 間的差異性拉大並延長血小板活性保持的時間,並且將左旋-精氨酸 基接枝在乙烯-乙烯醇共聚合物上並加入左旋-精氨酸作為添加劑可以 得到最好的實驗結果。 | zh_TW |
| dc.description.abstract | We fabricated poly(vinyl chloride) 、poly(vinyl alcohol) and
poly(ethylene-co-vinyl alcohol) polymer membranes by the method of dry processing. Diamine was grafted on the PVC membrane surface by the chemical reaction with the chloride groups. Diisocyanate was grafted on EAVL and PVA membrane surfaces by chemical reaction with the hydroxyl groups. Afterwards, amino group were grafted on these membranes. Also, we analyzed the surface properties of these membranes by means of Micro-ATR、Orange II salt and contact angles. To investigate the platelet storage condition and its qualities with diff. polymer membranes and L-Arginine effects, we used the cell viability method;MTT and LDH、platelet aggregation test、platelet surface marker labeling assay with flow cytomerty, clouding P-Selectin、GpIIb-IIIa complex and Survival-Apoptosis ratio, and platelet adhesion and shape change using take SEM picture. Post-storage platelet were shown the less adhesion and better qualities maintain on the modified membranes, we believed that course with the modified membrane were to provide more hydrophilic condition that can inhibit platelet adhesive on the polymer membranes. When we used L-Arginine to regard as the storage addition solution, we can get more better results on each experimental groups. But L-Arginine effect were lost after 3days. In order to solve this problem, we designed the membrane;EVAL grafting the L-Arginine on the membrane surface, the experiment result were shown the most less platelet adhesion number and best qualities maintain. So, we believe the membrane modification and additive L-Arginine solution to regard as addition solution can effectively improve platelet storage condition and its storage qualities. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-13T05:45:40Z (GMT). No. of bitstreams: 1 ntu-95-R93548004-1.pdf: 13226256 bytes, checksum: 6b0956e28487193694428fed1bc3dfd9 (MD5) Previous issue date: 2006 | en |
| dc.description.tableofcontents | 摘要............................................................................................................. I
ABSTRACT..............................................................................................II 目錄...........................................................................................................III 圖表索引....................................................................................................V 第一章 緒論...............................................................................................6 第二章 文獻回顧......................................................................................8 2-1 高分子材料..................................................................................8 2-1-1 生物醫學材料............................................................................8 2-1-2 聚氯乙烯....................................................................................9 2-1-3 聚乙烯醇..................................................................................10 2-1-4 乙烯-乙烯醇共聚物.................................................................11 2-2 高分子薄膜.................................................................................11 2-2-1 薄膜的定義..............................................................................11 2-2-2 薄膜的結構..............................................................................11 2-2-3 薄膜的製備..............................................................................12 2-3 血小板相關簡介.........................................................................12 2-3-1 血小板簡介..............................................................................12 2-3-2 血小板運用簡介......................................................................13 2-3-3 高分子表面改質與血小板儲存之關係.................................13 2-3-4 酸鹼值、血液氣體與血小板儲存之關係:.........................14 2-3-5 血小板儲存袋與血小板儲存 之關係:...............................15 2-3-6 血小板添加劑與血小板儲存之關係:.................................16 2-3-7 左旋-精氨酸之簡介:.............................................................17 2-3-8 左旋-精氨酸與血小板之關係: ............................................17 第三章 材料及實驗方法........................................................................19 3-1 試藥與原料................................................................................19 3-2 試藥配製....................................................................................21 3-3 實驗儀器....................................................................................23 3-4 實驗流程....................................................................................27 3-4-1 薄膜製備.................................................................................28 3-4-2 薄膜改質.................................................................................29 3-4-2-1 PVC 表面改質......................................................................29 3-4-2-2 PVA 與EVAL 表面改質 – 接枝胺基................................30 3-4-2-3 EVAL 表面改質 – 接枝左旋-精氨酸................................30 IV 3-4-2-4 血小板來源..........................................................................31 3-4-3 材料物理性質測試..................................................................32 3-4-3-1 材料表面動態接觸角...........................................................32 3-4-3-2 材料表面特性分析...............................................................33 3-4-3-3 材料厚度分析.......................................................................34 3-4-4 血小板-材料相容性儲存測試................................................35 3-4-4-1 薄膜前處理...........................................................................35 3-4-4-2 血小板活化抗體測試...........................................................35 3-4-4-3 血液氣體分析.......................................................................36 3-4-4-4 血小板型態改變觀察與吸附..............................................36 3-4-4-5 血小板凝集測試...................................................................37 3-4-4-6 MTT Assay............................................................................38 3-4-4-8 LDH Assay............................................................................38 第四章 結果與討論................................................................................40 4-1 薄膜表面改質材料分析............................................................40 4-1-1 Micro-ATR ...............................................................................40 4-1-2 Orange II sodium salt ...............................................................40 4–2 材料改質前後表面接觸角(親、疏水性)之變化.....................41 4-3 材料改質前後厚度之變化........................................................41 4–4 血小板與材料接觸後活性之表現(MTT) ................................42 4-5 血小板與材料接觸後死亡情形之評估(LDH) .........................44 4-6 血小板凝集測試........................................................................45 4-7 血小板儲存酸鹼值之變化........................................................47 4-8 血液氣體分析 – pO2 .................................................................48 4-9 血液氣體分析 – pCO2 ..............................................................48 4-10 血小板活化測試 – P-Selectin(CD62p) ..................................48 4-11 血小板活化測試 – GpIIbIIIa complex(CD41a) .....................49 4-12 血小板存活/死亡測試 – .........................................................50 Survival/Apoptosis(Annexin V) ........................................................50 4-13 血小板型態改變與貼附..........................................................51 第五章 結論.............................................................................................54 參考文獻...................................................................................................60 | |
| dc.language.iso | zh-TW | |
| dc.subject | 血小板 | zh_TW |
| dc.subject | 聚氯乙烯 | zh_TW |
| dc.subject | 聚乙烯醇 | zh_TW |
| dc.subject | 乙烯-乙烯醇共聚合物 | zh_TW |
| dc.subject | 雙胺 | zh_TW |
| dc.subject | 左旋-精 | zh_TW |
| dc.subject | 氨酸 | zh_TW |
| dc.subject | L-Arginine | en |
| dc.subject | diamine | en |
| dc.subject | PVC | en |
| dc.subject | platelet | en |
| dc.subject | PVA | en |
| dc.subject | EVAL | en |
| dc.title | 高分子材料表面改質對血小板儲存條件之研究 | zh_TW |
| dc.title | Polymer Surface Modification Effect of Platelet Storage Condition Research | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 94-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 胡孝光(Siao-Guang Hu),楊銘乾(Ming-Chian Young),林東燦(Dong-Tsamn Lin) | |
| dc.subject.keyword | 血小板,聚氯乙烯,聚乙烯醇,乙烯-乙烯醇共聚合物,雙胺,左旋-精,氨酸, | zh_TW |
| dc.subject.keyword | platelet,PVC,EVAL,PVA,diamine,L-Arginine, | en |
| dc.relation.page | 99 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2006-07-14 | |
| dc.contributor.author-college | 工學院 | zh_TW |
| dc.contributor.author-dept | 醫學工程學研究所 | zh_TW |
| Appears in Collections: | 醫學工程學研究所 | |
Files in This Item:
| File | Size | Format | |
|---|---|---|---|
| ntu-95-1.pdf Restricted Access | 12.92 MB | Adobe PDF |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
